Eli Lilly (LLY) Cash & Equivalents Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
70.76% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-43.63% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
81.47% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-38.27% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
36.64% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
-3.76% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
19.09% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-11.96% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
-9.03% |
| Date | Value |
|---|
| Mar 31, 2026 |
70.76% |
| Dec 31, 2025 |
122.40% |
| Sep 30, 2025 |
190.65% |
| Jun 30, 2025 |
4.72% |
| Mar 31, 2025 |
25.73% |
| Dec 31, 2024 |
15.94% |
| Sep 30, 2024 |
41.51% |
| Jun 30, 2024 |
19.64% |
| Mar 31, 2024 |
-30.62% |
| Dec 31, 2023 |
36.36% |
| Sep 30, 2023 |
-9.04% |
| Jun 30, 2023 |
2.73% |
| Mar 31, 2023 |
44.19% |
| Dec 31, 2022 |
-45.87% |
| Sep 30, 2022 |
-30.91% |
| Jun 30, 2022 |
-18.54% |
| Mar 31, 2022 |
-18.09% |
| Dec 31, 2021 |
4.41% |
| Sep 30, 2021 |
5.37% |
| Jun 30, 2021 |
36.15% |
| Mar 31, 2021 |
76.72% |
| Dec 31, 2020 |
56.45% |
| Sep 30, 2020 |
129.91% |
| Jun 30, 2020 |
3.27% |
| Mar 31, 2020 |
-16.57% |
| Dec 31, 2019 |
-70.77% |
| Sep 30, 2019 |
-82.55% |
| Jun 30, 2019 |
-66.41% |
| Mar 31, 2019 |
-33.98% |
| Dec 31, 2018 |
22.37% |
| Sep 30, 2018 |
140.58% |
| Jun 30, 2018 |
122.07% |
| Mar 31, 2018 |
17.86% |
| Dec 31, 2017 |
42.65% |
| Sep 30, 2017 |
6.74% |
| Jun 30, 2017 |
-5.19% |
| Mar 31, 2017 |
13.40% |
| Dec 31, 2016 |
24.98% |
| Sep 30, 2016 |
7.73% |
| Jun 30, 2016 |
-2.34% |
| Mar 31, 2016 |
-24.71% |
| Dec 31, 2015 |
-5.30% |
| Sep 30, 2015 |
2.31% |
| Jun 30, 2015 |
-11.96% |
| Mar 31, 2015 |
-21.17% |
| Dec 31, 2014 |
1.08% |
| Sep 30, 2014 |
-27.54% |
| Jun 30, 2014 |
-0.55% |
| Mar 31, 2014 |
-1.23% |
| Dec 31, 2013 |
-4.69% |
| Sep 30, 2013 |
-17.87% |
| Jun 30, 2013 |
-12.87% |
| Mar 31, 2013 |
-4.50% |
| Dec 31, 2012 |
-32.14% |
| Sep 30, 2012 |
-19.38% |
| Jun 30, 2012 |
-28.91% |
| Mar 31, 2012 |
-36.64% |
| Dec 31, 2011 |
-1.18% |
| Sep 30, 2011 |
11.66% |
| Jun 30, 2011 |
18.40% |
| Mar 31, 2011 |
37.70% |
| Dec 31, 2010 |
34.29% |
| Sep 30, 2010 |
53.55% |
| Jun 30, 2010 |
55.42% |
| Mar 31, 2010 |
42.62% |
